Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

2.140 +0.030 (+1.42%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,687
Open 2.170
Bid (Size) 2.000 (3)
Ask (Size) 2.390 (10)
Prev. Close 2.110
Today's Range 2.059 - 2.170
52wk Range 0.3992 - 3.784
Shares Outstanding 8,321,342
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations
Via ACCESSWIRE
Biotricity Achieves $14 Million Revenue Run Rate in August 2023
Via ACCESSWIRE

Performance

YTD
+389.48%
+389.48%
1 Month
+3.88%
+3.88%
3 Month
+235.69%
+235.69%
6 Month
+360.22%
+360.22%
1 Year
+160.98%
+160.98%

More News

Read More
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
Via ACCESSWIRE
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
Via ACCESSWIRE
Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
Via ACCESSWIRE
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
Via ACCESSWIRE
Biotricity Reports Strong Start to Fiscal Year 2024
Via ACCESSWIRE
Biotricity Predicted To Achieve 44% Annual Growth Despite Market Risks, Analyst Says
Via Benzinga
Biotricity's Return On Capital Employed Overview
Via Benzinga
Biotricity: Q4 Earnings Insights
Via Benzinga
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications
Via ACCESSWIRE
Biotricity Regains Nasdaq Listing Compliance
Via ACCESSWIRE
Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th
Via ACCESSWIRE
Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare
Via ACCESSWIRE
Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
Via ACCESSWIRE
Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
Via ACCESSWIRE
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Biotricity Announces Reverse Stock Split
Via ACCESSWIRE
Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow
Via ACCESSWIRE
Nike, Constellation Brands And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Markets Turn More Bullish As Bank Shares Rise On Stress Test Results
Via Benzinga
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
Via News Direct
Exposures Product Safety
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.